Kymera Therapeutics KYMR Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's change in other assets?
- Kymera Therapeutics (KYMR) reported change in other assets of $3.57M in Q1 2026.
- How has Kymera Therapeutics's change in other assets changed year-over-year?
- Kymera Therapeutics's change in other assets increased by 228.4% year-over-year, from -$2.78M to $3.57M.
- What is the long-term trend for Kymera Therapeutics's change in other assets?
- Over 2 years (2022 to 2025), Kymera Therapeutics's change in other assets has grown at a 172.9% compound annual growth rate (CAGR), from $998K to $7.43M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.